BCRX

Nasdaq

BIOCRYST PHARMACEUTICALS INC

Latest disclosureSeptember 2, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 2 sales

Price by TradingView

Insider transactions 34

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 20 trades on this page.

Award disclosed

Jon P. Stonehouse

Director

Common Stock

Value context: $6.25K
Reported price: $9.70 / share

Award disclosed

Jill C. Milne

Director

Common Stock

Value context: $12.49K
Reported price: $9.70 / share

Award disclosed

Vincent Milano

Director

Common Stock

Value context: $11.24K
Reported price: $9.70 / share

Award disclosed

Amy E. McKee

Director

Common Stock

Value context: $6.25K
Reported price: $9.70 / share

Award disclosed

Steven Frank

Director

Common Stock

Value context: $12.49K
Reported price: $9.70 / share

Award disclosed

Jill C. Milne

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Jill C. Milne

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Steven K. Galson

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Steven K. Galson

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Alan G. Levin

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Alan G. Levin

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Steven Frank

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Steven Frank

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Machelle Sanders

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Machelle Sanders

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Vincent Milano

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Vincent Milano

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Jon P. Stonehouse

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Jon P. Stonehouse

Director

Automatic Stock Option Grant

Derivative security · not the ordinary share price.

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Amy E. McKee

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Common StockGrant or award	644$9.70 / share	$6.25K	Aug 31Filed Sep 2 · 2d later	SEC filing
Director	Common StockGrant or award	1,288$9.70 / share	$12.49K	Aug 31Filed Sep 2 · 2d later	SEC filing
Director	Common StockGrant or award	1,159$9.70 / share	$11.24K	Aug 31Filed Sep 2 · 2d later	SEC filing
Director	Common StockGrant or award	644$9.70 / share	$6.25K	Aug 31Filed Sep 2 · 2d later	SEC filing
Director	Common StockGrant or award	1,288$9.70 / share	$12.49K	Aug 31Filed Sep 2 · 2d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Automatic Stock Option GrantGrant or award	Derivative units33,540Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	15,294Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing

Showing the latest 20 of 32 trades. Show all 32 trades

Congress transactions 2

All Congress filings

Purchase disclosed

BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 10, 2026

Purchase disclosed

BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000882796
Latest public acceptance: Sep 2, 2026, 08:16 PM UTC
Score calculated: Oct 8, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Director

Common StockGrant or award

644$9.70 / share

$6.25K

Aug 31Filed Sep 2 · 2d later